Sinopharm's and Sinovac's vaccines are based on traditional technology that uses inactivated or dead virus, that cannot replicate in human cells, to trigger an immune response.
Answer
[default - edit me]
Question
What technology is used?
Sinopharm's and Sinovac's vaccines are based on traditional technology that uses inactivated or dead virus, that cannot replicate in human cells, to trigger an immune response.
Answer
?
Question
What technology is used?
Sinopharm's and Sinovac's vaccines are based on traditional technology that uses inactivated or dead virus, that cannot replicate in human cells, to trigger an immune response.
Answer
[default - edit me]
If you want to change selection, open document below and click on "Move attachment"
Unknown title ar holiday in mid-February. China also approved a vaccine from CanSinoBIO for militaryuse and the vaccine had been given to some 40,000 to 50,000 people, a CanSinoBIO executive said on Nov. 28. <span>What technology is used? Sinopharm's and Sinovac's vaccines are based on traditional technology that uses inactivated or dead virus, that cannot replicate in human cells, to trigger an immune response. The overall occurrence rate of adverse reactions of those COVID-19 shots is similar to those of other inactivated vaccines, and the occurrence rate of relatively serious adverse effects
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.